IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
IQVIA Laboratories has launched Site Lab Navigator, an advanced solution suite featuring innovative e-Requisition technology to streamline clinical trial lab workflows. The new system enables electronic submission of requisitions and lab specimen management, replacing manual paper processes.
Key features include:
- Seamless portal integration via IQVIA's One Home for Sites™
- Real-time sample tracking with courier data
- Guided kit replacement and online order management
- Real-time data validation
- Guided data entry to reduce errors
- Online sample collection guidance
Several top 10 pharmaceutical companies have already adopted the platform, which aims to reduce site administrative burden, improve data integrity, and accelerate trial outcomes through automated workflows and real-time data validation.
IQVIA Laboratories ha lanciato Site Lab Navigator, una suite di soluzioni avanzate che presenta una tecnologia innovativa di e-Requisition per semplificare i flussi di lavoro dei laboratori nelle sperimentazioni cliniche. Il nuovo sistema consente la presentazione elettronica delle richieste e la gestione dei campioni di laboratorio, sostituendo i processi manuali su carta.
Le caratteristiche principali includono:
- Integrazione senza soluzione di continuità del portale tramite One Home for Sites™ di IQVIA
- Tracciamento dei campioni in tempo reale con dati del corriere
- Sostituzione guidata dei kit e gestione degli ordini online
- Validazione dei dati in tempo reale
- Inserimento dei dati guidato per ridurre gli errori
- Guida alla raccolta dei campioni online
Numerose delle prime 10 aziende farmaceutiche hanno già adottato la piattaforma, che mira a ridurre il carico amministrativo dei siti, migliorare l'integrità dei dati e accelerare i risultati delle sperimentazioni attraverso flussi di lavoro automatizzati e validazione dei dati in tempo reale.
IQVIA Laboratories ha lanzado Site Lab Navigator, un conjunto de soluciones avanzadas que presenta tecnología innovadora de e-Requisition para optimizar los flujos de trabajo de los laboratorios en ensayos clínicos. El nuevo sistema permite la presentación electrónica de requisiciones y la gestión de muestras de laboratorio, reemplazando los procesos manuales en papel.
Las características clave incluyen:
- Integración fluida del portal a través de One Home for Sites™ de IQVIA
- Seguimiento de muestras en tiempo real con datos de mensajería
- Sustitución guiada de kits y gestión de pedidos en línea
- Validación de datos en tiempo real
- Ingreso de datos guiado para reducir errores
- Guía de recolección de muestras en línea
Varias de las 10 principales empresas farmacéuticas ya han adoptado la plataforma, que tiene como objetivo reducir la carga administrativa de los sitios, mejorar la integridad de los datos y acelerar los resultados de los ensayos a través de flujos de trabajo automatizados y validación de datos en tiempo real.
IQVIA Laboratories는 Site Lab Navigator를 출시했습니다. 이 고급 솔루션 세트는 임상 시험 실험실 작업 흐름을 간소화하기 위한 혁신적인 e-Requisition 기술을 특징으로 합니다. 새로운 시스템은 수동 종이 프로세스를 대체하여 전자적으로 요청서를 제출하고 실험실 샘플을 관리할 수 있게 합니다.
주요 기능은 다음과 같습니다:
- IQVIA의 One Home for Sites™를 통한 매끄러운 포털 통합
- 택배 데이터를 통한 실시간 샘플 추적
- 킷 교체 안내 및 온라인 주문 관리
- 실시간 데이터 검증
- 오류를 줄이기 위한 안내 데이터 입력
- 온라인 샘플 수집 안내
여러 상위 10개 제약 회사가 이미 이 플랫폼을 채택했으며, 이는 사이트의 관리 부담을 줄이고 데이터 무결성을 개선하며 자동화된 작업 흐름과 실시간 데이터 검증을 통해 시험 결과를 가속화하는 것을 목표로 하고 있습니다.
IQVIA Laboratories a lancé Site Lab Navigator, une suite de solutions avancées intégrant une technologie innovante d'e-Requisition pour rationaliser les flux de travail des laboratoires lors des essais cliniques. Le nouveau système permet la soumission électronique des demandes et la gestion des échantillons de laboratoire, remplaçant ainsi les processus manuels sur papier.
Les principales caractéristiques incluent :
- Intégration fluide du portail via One Home for Sites™ d'IQVIA
- Suivi des échantillons en temps réel avec données de messagerie
- Remplacement guidé des kits et gestion des commandes en ligne
- Validation des données en temps réel
- Saisie de données guidée pour réduire les erreurs
- Guide de collecte d'échantillons en ligne
Plusieurs des 10 principales entreprises pharmaceutiques ont déjà adopté la plateforme, qui vise à réduire la charge administrative des sites, améliorer l'intégrité des données et accélérer les résultats des essais grâce à des flux de travail automatisés et à la validation des données en temps réel.
IQVIA Laboratories hat Site Lab Navigator eingeführt, eine fortschrittliche Lösungssuite mit innovativer e-Requisition-Technologie, um die Arbeitsabläufe in klinischen Prüfungs-Laboren zu optimieren. Das neue System ermöglicht die elektronische Einreichung von Anträgen und das Management von Laborproben und ersetzt manuelle Papierprozesse.
Zu den Hauptfunktionen gehören:
- Nahtlose Portal-Integration über IQVIAs One Home for Sites™
- Echtzeit-Probenverfolgung mit Kurierdaten
- Geführte Kit-Ersetzung und Online-Bestellmanagement
- Echtzeit-Datenvalidierung
- Geführte Dateneingabe zur Fehlerreduzierung
- Online-Anleitung zur Probenentnahme
Mehrere der 10 größten Pharmaunternehmen haben die Plattform bereits übernommen, die darauf abzielt, die administrative Belastung der Standorte zu reduzieren, die Datenintegrität zu verbessern und die Ergebnisse von Studien durch automatisierte Arbeitsabläufe und Echtzeit-Datenvalidierung zu beschleunigen.
- Launch of innovative e-Requisition technology streamlining clinical trials
- Early adoption by several top 10 pharmaceutical companies
- Automation reduces administrative burden and errors
- Real-time data validation improves accuracy and reporting speed
- None.
Insights
IQVIA's launch of Site Lab Navigator represents a strategic enhancement to its clinical trial technology ecosystem, specifically addressing workflow bottlenecks at investigational sites. The e-Requisition solution tackles one of the most persistent pain points in clinical trials - manual sample management and paper-based requisition processes. This digital transformation initiative aligns with the industry's broader push toward decentralized and technology-enabled trials.
The solution's early adoption by several top 10 pharmaceutical companies indicates market validation and potential for meaningful implementation across IQVIA's extensive clinical trial network. What's particularly notable is the integration with IQVIA's One Home for Sites platform, creating an interoperable ecosystem rather than just a standalone solution.
From an operational perspective, the workflow automation should reduce error rates and accelerate reporting timelines - factors that directly impact trial efficiency and data quality. Real-time validation and simplified workflows address key friction points that typically delay trial execution and increase costs. While the announcement lacks specific efficiency metrics or ROI figures, the focus on eliminating manual processes suggests meaningful operational improvements for both IQVIA's laboratory services and their client sites.
This product launch represents IQVIA's continued investment in technology-enabled service offerings that increase stickiness with both pharmaceutical sponsors and clinical trial sites. The e-Requisition solution within Site Lab Navigator addresses a specific operational inefficiency within the clinical trial ecosystem, potentially strengthening IQVIA's competitive position in laboratory services.
While the financial impact remains unquantified, the development aligns with IQVIA's long-term strategy of creating integrated technology platforms that connect various stakeholders in the clinical trial process. The mention of early adoption by several top 10 pharmaceutical companies suggests the solution has already gained commercial traction, though revenue contribution is likely to build gradually as implementation expands.
From a business perspective, this enhancement to IQVIA Laboratories' offerings helps differentiate their services in an increasingly competitive market. The technology appears aimed at reducing administrative burden and improving compliance - both key pain points for trial sponsors that directly impact costs. While not revolutionary, this incremental innovation strengthens IQVIA's value proposition in laboratory services, a segment where efficiency and accuracy translate directly to client satisfaction and retention. The real-time data validation and streamlined workflows should help address quality concerns that often plague clinical trials, potentially reducing costly delays and data issues.
At the core of Site Lab Navigator is a new, innovative e-Requisition solution, which allows investigator sites to submit requisitions and manage lab specimens electronically, eliminating the need for manual, paper-based processes. This reduces administrative burden, minimizes errors, drives compliance and improves study execution for both sponsors and investigator sites.
IQVIA Laboratories’ e-Requisition solution within the Site Lab Navigator suite of applications is a unique technology solution that offers capabilities unmatched by other requisitioning solutions available:
- Seamless portal integration: Easy access via IQVIA’s One Home for Sites™ single sign-on.
- Real-time sample tracking: End-to-end shipping visibility using courier data.
- Guided kit replacement: Online kit order management to minimize waste.
- Real-time data validation: Improved accuracy and acceleration of reporting times.
- Guided data entry: Elimination of data recording errors resulting in significant reduction in visit queries and streamlined patient reporting and database locks.
- Online sample collection guidance: Simplified workflows, reducing site burden and ensuring compliance.
“Site Lab Navigator and its differentiated e-Requisition solution will significantly reduce administrative burden on sites and improve the quality and execution of clinical trials for our customers,” said David Morris, chief operating officer at IQVIA Laboratories. “The early response has been extremely positive, with a number of sponsors already signed on including several top 10 pharmaceutical companies. By equipping investigator sites with cutting-edge tools, we are streamlining workflows, improving data integrity and ultimately accelerating the path to high-quality results.”
With automation of workflows, real-time validation of data captured and an intuitive user experience, the new e-Requisition solution reinforces IQVIA Laboratories’ dedication to delivering innovative, site-centric solutions that drive faster, more accurate and efficient trial outcomes.
For more information about Site Lab Navigator and e-Requisition, visit www.labs.iqvia.com/investigator-support.
About IQVIA Laboratories
IQVIA Laboratories is a leading global drug discovery and development laboratory services organization offering a comprehensive suite of central laboratory and specialty biomarker services. Our expertise spans central laboratory, genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine, vaccine, ADME, and bioanalytical services. IQVIA Laboratories also brings extensive expertise in antibody drug discovery, biomarker discovery, and decentralized clinical trial laboratory solutions.
With a commitment to scientific excellence and operational efficiency, IQVIA Laboratories supports the entire drug development lifecycle across diverse regions and regulatory landscapes, ensuring data integrity and optimizing research to bring life-changing therapies to patients faster. To learn more visit www.labs.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250304097031/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com)
+1.919.923.6785
Source: IQVIA
FAQ
What are the key features of IQVIA's new Site Lab Navigator platform?
How does IQVIA's e-Requisition solution improve clinical trial efficiency?
Which companies have adopted IQVIA's Site Lab Navigator solution?
What are the main benefits of IQVIA's Site Lab Navigator for clinical trial sites?
